Risk factors for Clostridium difficile infection in hospitalized patients with community-acquired pneumonia

Journal of Infection

Volumn 73, Issue 1, 2016, Pages 45-53

  Chalmers, James D ^a   Akram, Ahsan R ^b   Singanayagam, Aran ^c   Wilcox, Mark H ^d   Hill, Adam T ^b  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^d LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

Antibiotics; Clostridium difficile; Healthcare associated infections; Macrolides; Pneumonia

Indexed keywords

ADULT; AGE; AGED; ANTIBIOTIC THERAPY; ARTICLE; CLOSTRIDIUM DIFFICILE INFECTION; COHORT ANALYSIS; COMMUNITY ACQUIRED PNEUMONIA; DIARRHEA; FEMALE; HOSPITAL PATIENT; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PROSPECTIVE STUDY; RISK FACTOR; TREATMENT DURATION; UNITED KINGDOM; CHEMICALLY INDUCED; CLOSTRIDIUM INFECTIONS; COMMUNITY-ACQUIRED INFECTIONS; COMPLICATION; DRUG UTILIZATION; HOSPITALIZATION; INCIDENCE; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; PEPTOCLOSTRIDIUM DIFFICILE; PNEUMONIA;

ANTIINFECTIVE AGENT;

AGED; ANTI-BACTERIAL AGENTS; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; COMMUNITY-ACQUIRED INFECTIONS; DIARRHEA; DRUG UTILIZATION; FEMALE; HOSPITALIZATION; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PNEUMONIA; PROSPECTIVE STUDIES; RISK FACTORS; UNITED KINGDOM;

EID: 84964682253     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2016.04.008     Document Type: Article

References (41)

1. Slimings C., Riley T.V. Antibiotics and hospital-acquired Clostridium difficile infection: update of systematic review and meta-analysis. J Antimicrob Chemother 2014, 69:881-891.
2. Lessa F.C., Mu Y., Bamberg W.M., Beldavs Z.G., Dumyati G.K., Dunn J.R., et al. Burden of Clostridium difficile infection in the United States. N Engl J Med 2015, 372:825-834.
3. Wilcox M.H., Shetty N., Fawley W.N., Shemko M., Coen P., Birtles A., et al. Changing epidemiology of Clostridium difficile infection following the introduction of a national ribotyping-based surveillance scheme in England. Clin Infect Dis 2012, 55:1056-1063.
4. Banaei N., Anikst V., Schroeder L.F. Burden of Clostridium difficile infection in the United States. N Engl J Med 2015, 372:2368-2369.
5. Planche T.D., Davies K.A., Coen P.G., Finney J.M., Monahan I.M., Morris K.A., et al. Differences in outcome according to Clostridium difficile testing method: a prospective multicentre diagnostic validation study of C. difficile infection. Lancet Infect Dis 2013, 13:936-945.
6. Public Health England. Clostridium difficile: guidance, data and analysis. Annual counts and rates of C. difficile infections by acute trust and clinical commissioning group (CCG) in patients aged 2 years and over. [accessed 25.06.15]. https://www.gov.uk/government/statistics/clostridium-difficile-infection-annual-data.
7. Singayagam A., Chalmers J.D., Hill A.T. Severity assessment in community-acquired pneumonia: a review. QJM 2009, 102:379-388.
8. Chalmers J.D., Al-Khairalla M., Short P.M., Fardon T.C., Winter J.H. Proposed changes to management of lower respiratory tract infections in response to the Clostridium difficile epidemic. J Antimicrob Chemother 2010, 65:608-618.
9. Impallomeni M., Galletly N.P., Wort S.J., Starr J.M., Rogers T.R. Increased risk of diarrhoea caused by Clostridium difficile in elderly patients receiving cefotaxime. BMJ 1995, 311:1345-1346.
10. Wilcox M.H. Respiratory antibiotic use and Clostridium difficile infection: is it the drugs or is it the doctors?. Thorax 2000, 55:633-634.
11. Trotter C.L., Stuart J.M., George R., Miller E. Increasing hospital admissions for pneumonia, England. Emerg Infect Dis 2008, 14:727-733.
12. Health Protection Agency. Clostridium difficile infection: How to deal with the problem. [accessed 25.06.15]. https://www.gov.uk/government/publications/clostridium-difficile-infection-how-to-deal-with-the-problem.
13. Khanna S., Pardi D.S. Clostridium difficile infection: new insights into management. Mayo Clin Proc 2012, 87:1106-1117.
14. Becerra M.B., Becerra B.J., Banta J.E., Safdar N. Impact of Clostridium difficile infection among pneumonia and urinary tract infection hospitalizations: an analysis of the Nationwide Inpatient Sample. BMC Infect Dis 2015, 15:254.
15. Chalmers J.D., Taylor J.K., Singanayagam A., Fleming G.B., Akram A.R., Mandal P., et al. Epidemiology, antibiotic therapy, and clinical outcomes in health care-associated pneumonia: a UK cohort study. Clin Infect Dis 2011, 53:107-113.
16. Chalmers J.D., Singanayagam A., Akram A.R., Choudhury G., Mandal P., Hill A.T. Safety and efficacy of CURB65-guided antibiotic therapy in community-acquired pneumonia. J Antimicrob Chemother 2011, 66:416-423.
17. Choudhury G., Chalmers J.D., Mandal P., Akram A.R., Murray M.P., Short P., et al. Physician judgement is a crucial adjunct to pneumonia severity scores in low-risk patients. Eur Respir J 2011, 38:643-648.
18. American Thoracic Society/Infectious Diseases Society of America Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005, 171:388-416.
19. Peduzzi P., Concato J., Kemper E., Holford T.R., Feinstein A.R. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol 1996, 49:1373-1379.
20. Altman D.G., Bland J.M. Interaction revisited: the difference between two estimates. BMJ 2003, 326:219.
21. Barker B., Macfarlane J., Lim W.S., Douglas G. Local guidelines for management of adult community acquired pneumonia: a survey of UK hospitals. Thorax 2009, 64:181.
22. Lim W.S., Baudouin S.V., George R.C., Hill A.T., Jamieson C., Le Jeune I., et al. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax 2009, 64(Suppl. 3):iii1-iii55.
23. Mandell L.A., Wunderink R.G., Anzueto A., Bartlett J.G., Campbell G.D., Dean N.C., et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007, 44(Suppl. 2):S27-S72.
24. British Thoracic Society. BTS Guidelines for the Management of Community Acquired Pneumonia in Adults: 2004 Update. [accessed 25.06.15]. https://www.brit-thoracic.org.uk/document-library/clinical-information/pneumonia/adult-pneumonia/adult-cap-guideline-2001/guidelines-for-the-management-of-community-acquired-pneumonia-in-adults-2004-update/.
25. British Thoracic Society. BTS Guidelines for the Management of Community Acquired Pneumonia in Adults: 2009 Update. [accessed 26.06.15]. https://www.brit-thoracic.org.uk/document-library/clinical-information/pneumonia/adult-pneumonia/bts-guidelines-for-the-management-of-community-acquired-pneumonia-in-adults-2009-update/.
26. Llewelyn M.J., Hand K., Hopkins S., Walker A.S. Antibiotic policies in acute English NHS trusts: implementation of 'Start Smart-Then Focus' and relationship with Clostridium difficile infection rates. J Antimicrob Chemother 2015, 70:1230-1235.
27. Health Protection Scotland. The Annual Surveillance of Healthcare Associated Infection Report January - December 2009. [accessed 25.06.15]. http://www.documents.hps.scot.nhs.uk/hai/annual-report/annual-surveillance-hai-report-2009.pdf.
28. Oughton M.T., Loo V.G., Dendukuri N., Fenn S., Libman M.D. Hand hygiene with soap and water is superior to alcohol rub and antiseptic wipes for removal of Clostridium difficile. Infect Control Hosp Epidemiol 2009, 30:939-944.
29. Brown K., Valenta K., Fisman D., Simor A., Daneman N. Hospital ward antibiotic prescribing and the risks of Clostridium difficile infection. JAMA Intern Med 2015, 175:626-633.
30. Thomas C., Stevenson M., Riley T.V. Antibiotics and hospital-acquired Clostridium difficile-associated diarrhoea: a systematic review. J Antimicrob Chemother 2003, 51:1339-1350.
31. Bruns A.H., Oosterheert J.J., Kuijper E.J., Lammers J.W., Thijsen S., Troelstra A., et al. Impact of different empirical antibiotic treatment regimens for community-acquired pneumonia on the emergence of Clostridium difficile. J Antimicrob Chemother 2010, 65:2464-2471.
32. Davey P., Brown E., Fenelon L., Finch R., Gould I., Holmes A., et al. Systematic review of antimicrobial drug prescribing in hospitals. Emerg Infect Dis 2006, 12:211-216.
33. Pepin J., Saheb N., Coulombe M.A., Alary M.E., Corriveau M.P., Authier S., et al. Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec. Clin Infect Dis 2005, 41:1254-1260.
34. Deshpande A., Pasupuleti V., Thota P., Pant C., Rolston D.D., Sferra T.J., et al. Community-associated Clostridium difficile infection and antibiotics: a meta-analysis. J Antimicrob Chemother 2013, 68:1951-1961.
35. Postma D.F., van Werkhoven C.H., van Elden L.J., Thijsen S.F., Hoepelman A.I., Kluytmans J.A., et al. Antibiotic treatment strategies for community-acquired pneumonia in adults. N Engl J Med 2015, 372:1312-1323.
36. Choudhury G., Mandal P., Singanayagam A., Akram A.R., Chalmers J.D., Hill A.T. Seven-day antibiotic courses have similar efficacy to prolonged courses in severe community-acquired pneumonia-a propensity-adjusted analysis. Clin Microbiol Infect 2011, 17:1852-1858.
37. el Moussaoui R., de Borgie C.A., van den Broek P., Hustinx W.N., Bresser P., van den Berk G.E., et al. Effectiveness of discontinuing antibiotic treatment after three days versus eight days in mild to moderate-severe community acquired pneumonia: randomised, double blind study. BMJ 2006, 332:1355.
38. Aliberti S., Peyrani P., Filardo G., Mirsaeidi M., Amir A., Blasi F., et al. Association between time to clinical stability and outcomes after discharge in hospitalized patients with community-acquired pneumonia. Chest 2011, 140:482-488.
39. Murray C., Shaw A., Lloyd M., Smith R.P., Fardon T.C., Schembri S., et al. A multidisciplinary intervention to reduce antibiotic duration in lower respiratory tract infections. J Antimicrob Chemother 2014, 69:515-518.
40. Akram A.R., Chalmers J.D., Taylor J.K., Rutherford J., Singanayagam A., Hill A.T. An evaluation of clinical stability criteria to predict hospital course in community-acquired pneumonia. Clin Microbiol Infect 2013, 19:1174-1180.
41. Eastwood K., Else P., Charlett A., Wilcox M. Comparison of nine commercially available Clostridium difficile toxin detection assays, a real-time PCR assay for C. difficile tcdB, and a glutamate dehydrogenase detection assay to cytotoxin testing and cytotoxigenic culture methods. J Clin Microbiol 2009, 47:3211-3217.